Betel Quid Use Linked to Higher Risk of COPD Deaths, Study Finds

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-09-14 15:30 GMT   |   Update On 2025-09-14 15:30 GMT
Advertisement

USA: Betel quid chewing—common across South and Southeast Asia—may significantly raise the risk of dying from chronic respiratory diseases, particularly chronic obstructive pulmonary disease (COPD), according to a large prospective study published in the journal CHEST.

Researchers led by Keenan Duggal of NYU Grossman School of Medicine report that habitual users faced markedly higher odds of respiratory-related death, independent of
Advertisement
cigarette smoking
and other known risk factors.
The team tracked 20,033 adults aged 18 to 75 years from Araihazar, Bangladesh, over a follow-up period spanning October 2000 to April 2024. During this time, 476 participants died from respiratory illnesses. Baseline information—including age, sex, education, body mass index, smoking history, and detailed patterns of betel quid use—was collected through standardized questionnaires. Using Cox proportional hazards models, the investigators assessed how betel quid habits influenced the likelihood of dying from respiratory conditions.
The analysis revealed the following findings:
  • Individuals who had ever chewed betel quid showed a 38% higher risk of death from respiratory disease compared with non-users (hazard ratio [HR] 1.38).
  • COPD-related mortality risk increased by 56% among betel quid users (HR 1.56).
  • No significant association was observed between betel quid use and lung cancer mortality (HR 1.24).
  • A dose–response trend was evident:
    • Low levels of betel quid consumption were linked to a 46% higher risk of COPD mortality (HR 1.46).
    • Heavy use was associated with more than double the risk (HR 2.47) compared with never users.
  • These associations persisted regardless of demographic or lifestyle factors and were particularly pronounced among:
    • Women (HR 3.63)
    • Non-smokers (HR 3.44)
  • The researchers estimated that 16% of COPD deaths in the cohort could be attributed to betel quid use.
Betel quid—a preparation typically containing areca nut, slaked lime, and often tobacco—has long been linked to oral cancers and cardiovascular disease. The study adds strong prospective evidence that its harm extends to chronic respiratory illnesses as well. Because the analysis adjusted for smoking, body weight, education level, and other potential confounders, the findings underscore betel quid as an independent risk factor for fatal COPD.
The authors call for urgent public health measures to curb betel quid consumption, highlighting the need for community education, clinical screening, and policy interventions. With millions of users across Asia and migrant communities worldwide, they warn that failing to address this habit could exacerbate the global burden of respiratory disease.
The study provides some of the most robust data to date on the lethal respiratory consequences of betel quid, reinforcing the call for clinicians and policymakers to treat this culturally ingrained practice as a serious health hazard.
Reference:
Duggal, K., Wu, F., Parvez, F., Ahmed, A., Hasan, R., Shima, S. A., Sarwar, G., Rakibuz-Zaman, M., Ahmmed, G., Shahriar, M. H., Ahsan, H., & Chen, Y. (2025). Association between betel quid consumption and respiratory disease mortality in a prospective Bangladeshi cohort. CHEST. https://doi.org/10.1016/j.chest.2025.08.030
Tags:    
Article Source : journal CHEST

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News